Nicotinic agonist modulation of neurotransmitter levels in the rat frontoparietal cortex

Japanese Journal of Pharmacology

Volumn 74, Issue 2, 1997, Pages 139-146

  Summers, Kathleen L ^a   Kem, William R ^b   Giacobini, Ezio ^a,c  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

Acetylcholine; Alzheimer's therapy; Mecamylamine; Microdialysis; Nicotinic agonist

Indexed keywords

3 (2,4 DIMETHOXYBENZYLIDENE)ANABASEINE; ACETYLCHOLINE; ANABASINE; DOPAMINE; MECAMYLAMINE; NEUROTRANSMITTER; NICOTINE; NICOTINIC AGENT; NICOTINIC RECEPTOR; NORADRENALIN; RECEPTOR SUBTYPE; SEROTONIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG SELECTIVITY; DRUG STRUCTURE; FRONTAL CORTEX; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MICRODIALYSIS; NONHUMAN; PARIETAL LOBE; RAT; RECEPTOR AFFINITY; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030858491     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.74.139     Document Type: Article

References (43)

1. Newhouse PA, Potter A and Lenox RH: The effects of nicotinic agents on human cognition: possible therapeutic applications in Alzheimer's and Parkinson's Diseases. Med Chem Res 2, 628-642 (1993)
2. Decker M, Brioni J, Bannon A and Arneric S: Diversity of neuronal nicotinic acetylcholine receptors: lessons from behavior and implications for CNS therapeutics. Life Sci 56, 545-570 (1995)
3. Kem WR, Abbott BC and Coates RM: Isolation and structure of a hoplonemertine toxin. Toxicon 9, 15-22 (1971)
4. Kem WR, Mahnir VM, Lin BL and Prokai-Tatrai K: Two primary metabolites of GTS-21 are potent alpha7 nicotinic agonists. Proc Fifth Intern Conf Alzheimer's Disease, Abstract 36, S10 (1996)
5. Kem WR and Papke RL: Actions of anabaseine and DMAB-anabaseine upon neuronal and PC12 cell nicotinic receptors. Soc Neurosci Abstr 18, 1358 (1992)
6. Meyer WM, de Fiebre CM, Hunter BE, Simpkins CE, Frauworth N and de Fiebre NE: Effects of anabaseine-related analogs on rat brain nicotinic receptor binding and on avoidance behaviors. Drug Dev Res 31, 127-134 (1994)
7. Papke RL, de Fiebre CM, Kem WR and Meyer EM: The subunit specific effects of novel anabaseine-derived nicotinic agents. In Alzheimer Disease: Therapeutic Strategies, Edited by Giacobini E and Becker R, pp 206-211, Birkhäuser, Boston (1994)
8. 125I-α-bungarotoxin receptor subtypes. Mol Pharmacol 47, 164-171 (1995)
9. Woodruff-Pak DS, Li Y-T and Kem WR: A nicotinic receptor agonist (GTS-21), eyeblink classical conditioning, and nicotinic receptor binding in rabbit brain. Brain Res 645, 309-317 (1994)
10. Arendash GW, Sengstock GJ, Sanberg PR and Kem WR: Improved learning and memory in aged rats with chronic administration of the nicotinic receptor agonist GTS-21. Brain Res 674, 252-259 (1995)
11. Toide K and Arima T: Effects of cholinergic drugs on extracellular levels of acetylcholine and choline in rat cortex, hippocampus and striatum studied by brain dialysis. Eur J Pharmacol 173, 133-141 (1989)
12. Toth E, Sershen H, Hashim A, Vizi ES and Lajtha A: Effect of nicotine on extracellular levels of neurotransmitters assessed by microdialysis in various brain regions: role of glutamic acid. Neurochem Res 17, 265-271 (1992)
13. Ribeiro EB, Bettiker RL, Bogdanov M and Wurtman RJ: Effects of systemic nicotine on serotonin release in rat brain. Brain Res 621, 311-318 (1993)
14. Summers KL, Cuadra G, Naritoku D and Giacobini E: Effects of nicotine on levels of acetylcholine and biogenic amines in rat cortex. Drug Dev Res 31, 108-119 (1994)
15. Summers KL and Giacobini E: Effects of local and repeated systemic administration of (-)nicotine on extracellular levels of acetylcholine, norepinephrine, dopamine, and serotonin in rat cortex. Neurochem Res 20, 753-759 (1995)
16. Summers KL, Lippiello P, Verhulst S and Giacobini E: 5-Fluoro-nicotine, noranydroecgonine, and pyridyl-methylpyrrolidine release acetylcholine and biogenic amines in rat cortex in vivo. Neurochem Res 20, 1089-1094 (1995)
17. Bloom LB: Influence of solvent on the ring-chain hydrolysis equilibrium of anabaseine and syntheses of anabaseine and nicotine analogues. Ph D Dissertation, University of Florida (1990)
18. Kem WR: A study of the occurrence of anabaseine in Paranemertes and other nemertines. Toxicon 9, 23-32 (1971)
19. Zoltewicz JA, Prokai-Tatrai K, Bloom LB and Kem WR: Long range transmission of polar effects of cholinergic 3-arylidene-anabaseines. Conformations molecular modelling. Heterocycles 35, 171-179 (1993)
20. 3H]acetylcholine release in the rat cerebral cortex. J Neurochem 49, 1758-1762 (1987)
21. 3H]methylcarbamylcholine binding sites and effect of N-methylcarbamylcholine on acetylcholine release in rat brain. J Neurochem 41, 292-299 (1988)
22. Toide K, Shinoda M and Iwata K: Effects of cholinergic drugs on in vivo release of ACh from the frontal cortex and hippocampus studied by microdialysis. In Monitoring Molecules in Neuroscience, Edited by Rollema H, Westerink B and Drijfhout WJ, pp 285-287, Univ Cent Pharmacy, Groningen (1991)
23. Flores CM, Rogers SW, Pabreza LA, Wolfe B and Kellar KJ: A subtype of nicotinic cholinergic receptor is composed of alpha4 and beta2 subunits and is up-regulated by chronic nicotine treatment. Mol Pharmacol 41, 11-37 (1992)
24. Sahin M, Bowen WD and Donoghue JP: Location of nicotinic and muscarinic cholinergic and μ-opiate receptors in rat cerebral neocortex: evidence from thalamic and cortical lesions. Brain Res 579, 135-147 (1992)
25. Kem WR, Mahnir VM, Lin B and Prokai-Tatrai K: Two primary GTS-21 metabolites are potent partial agonists at alpha7 nicotinic receptors expressed in the Xenopus oocyte. Soc Neurosci Abstr 20, 268 (1996)
26. 3 receptors expressed in Xenopus oocytes. Soc Neurosci Abstr 22, 1780 (1996)
27. 3 receptors mediate inhibition of acetylcholine release in cortical tissue. Nature 338, 762-763 (1989)
28. Zaborsky L, Heimer L, Eckenstein F and Leranth C: GABAergic input to cholinergic forebrain neurons: an ultrastructural study using retrograde tracing of HRP and double immunolabeling. J Comp Neurol 250, 282-295 (1986)
29. Lena C, Changeux J-P and Mulle C: Evidence for "preterminal" nicotinic receptors on GABAergic axons in the rat interpeduncular nucleus. J Neurosci 13, 2680-2688 (1993)
30. Vidal C: Nicotinic potentiation of glutamatergic synapses in the prefrontal cortex: new insight into the analysis of the role of nicotinic receptors in cognitive functions. Drug Dev Res 31, 120-126 (1994)
31. Lukas RJ: Pharmacological distinctions between functional nicotinic acetylcholine receptors on the PC12 rat pheochromocytoma and the TE671 human medulloblastoma. J Pharmacol Exp Ther 251, 175-182 (1989)
32. Briggs CA and McKenna DG: Effect of MK-801 at the human alpha7 nicotinic acetylcholine receptor. Neuropharmacology 35, 407-414 (1996)
33. Zorumski CF, Thio L, Isenberg KE and Clifford DB: Nicotinic acetylcholine currents in cultured postnatal rat hippocampal neurons. Mol Pharmacol 41, 931-936 (1992)
34. Collins AC, Evans CB, Miner LL and Marks MJ: Mecamylamine blockade of nicotine responses: evidence for two brain nicotinic receptors. Pharmacol Biochem Behav 24, 1767-1773 (1986)
35. Luntz-Leyban V, Bickford PC and Freedman R: Cholinergic gating of response to auditory stimuli in rat hippocampus. Brain Res 587, 130-136 (1992)
36. Curzon P, Kim DJB and Decker MW: Effect of nicotine, lobeline, and mecamylamine on sensory gating in the rat. Pharmacol Biochem Behav 49, 877-882 (1994)
37. Olney JW, Price MT, Labruyere J, Salles KS, Friedrich G, Mueller M and Siverman E: Anti-parkinsonian agents are phencyclidine agonists and N-methyl-aspartate antagonists. Eur J Pharmacol 142, 319-320 (1987)
38. 3H-(1-[1-(2-thienyl)cyclohexyl]-piperidine) binding in rat hippocampus. Synapse 3, 129-135 (1989)
39. Quirion R, Richard J and Dam TV: Evidence for the existence of serotonin type-2 receptors on cholinergic terminals in rat cortex. Brain Res 333, 345-349 (1985)
40. Hirano H, Day J and Fibiger HC: Serotonergic regulation of acetylcholine release in rat frontal cortex. J Neurochem 65, 1139-1145 (1995)
41. 1B receptors. J Pharmacol Exp Ther 277, 823-830 (1996)
42. Toide K: Effects of scopolamine on extracellular acetylcholine and choline levels and on spontaneous motor activity in freely moving rats measured by brain dialysis. Pharmacol Biochem Behav 33, 110-113 (1989)
43. Quirion R, Richard J and Wilson A: Muscarinic and nicotinic modulation of cortical acetylcholine release monitored by in vivo microdialysis in freely moving adult rats. Synapse 17, 92-100 (1994)